NYBC Ventures key facts
- NYBC Ventures is a venture capital firm based in Boston, Massachusetts with 11 tracked portfolio companies.
- Notable positions include AvenCell, Veralox Therapeutics, Immusoft.
- The team roster lists 1 person.
About NYBC Ventures
Founded in 2022, NYBC Ventures is the corporate venture capital arm of New York Blood Center, based in Boston, Massachusetts. The firm prefers to invest in early-stage companies operating in the cell therapy, transfusion medicine, benign hematology, and infectious disease sectors, of which emerging technologies, including in-vivo cell therapy, gene editing, iPSC, and regenerative medicine, are of interest.
NYBC Ventures portfolio at a glance
11 portfolio companies are on record for NYBC Ventures, including AvenCell, Veralox Therapeutics and Immusoft.
7 of the 11 carry a recorded valuation.
NYBC Ventures team
1 person is on record at NYBC Ventures. Senior names include Jay Mohr (General Partner). 1 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 11 recorded positions
- ·Watchlist + alerts for NYBC Ventures's activity
Portfolio
11 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| AvenCell | — | ▮ | ▮ | ▮ |
| Veralox Therapeutics | — | ▮ | ▮ | ▮ |
| Immusoft | — | ▮ | ▮ | ▮ |
+ 8 more companies · all 11, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about NYBC Ventures
- What companies does NYBC Ventures invest in?
- NYBC Ventures has 11 recorded portfolio companies, including AvenCell, Veralox Therapeutics, Immusoft.
- What is NYBC Ventures's AUM?
- NYBC Ventures manages approximately $50.0M in assets.